$LPCN
Lipocine Inc.

2015 Q4 Form 10-K Financial Statement

#000114420416087232 Filed on March 10, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2015 2014 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.930M $5.800M $1.170M
YoY Change 64.96% 16.0% 13.59%
% of Gross Profit
Research & Development $2.770M $12.58M $2.890M
YoY Change -4.15% -18.73% 17.48%
% of Gross Profit
Depreciation & Amortization $10.00K $30.00K $0.00
YoY Change 200.0%
% of Gross Profit
Operating Expenses $4.700M $18.38M $4.060M
YoY Change 15.76% -10.25% 16.0%
Operating Profit -$4.696M -$18.38M
YoY Change -10.25%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $60.00K $170.0K $20.00K
YoY Change 200.0% 54.55% 0.0%
Pretax Income -$4.630M -$18.21M -$4.040M
YoY Change 14.6% -10.62% -7.97%
Income Tax $0.00 $200.00 $0.00
% Of Pretax Income
Net Earnings -$4.634M -$18.21M -$4.040M
YoY Change 14.7% -10.62% -7.97%
Net Earnings / Revenue
Basic Earnings Per Share -$0.25 -$1.11
Diluted Earnings Per Share -$0.25 -$1.11 -$316.4K
COMMON SHARES
Basic Shares Outstanding 18.25M shares 16.47M shares 12.79M shares
Diluted Shares Outstanding 16.47M shares

Balance Sheet

Concept 2015 Q4 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.38M $44.38M $27.67M
YoY Change 60.39% 60.39% -38.86%
Cash & Equivalents $20.01M $20.01M $27.67M
Short-Term Investments $24.38M $24.38M
Other Short-Term Assets $350.0K $350.0K $230.0K
YoY Change 52.17% 52.17% -70.13%
Inventory
Prepaid Expenses
Receivables $140.0K $140.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $44.88M $44.88M $27.90M
YoY Change 60.87% 60.86% -39.4%
LONG-TERM ASSETS
Property, Plant & Equipment $75.75K $80.00K $73.78K
YoY Change 2.67% 14.29% 156.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $400.0K $400.0K
YoY Change
Other Assets $23.75K $20.00K $23.75K
YoY Change 0.0% 0.0% -47.22%
Total Long-Term Assets $499.8K $500.0K $97.54K
YoY Change 412.39% 455.56% 32.17%
TOTAL ASSETS
Total Short-Term Assets $44.88M $44.88M $27.90M
Total Long-Term Assets $499.8K $500.0K $97.54K
Total Assets $45.38M $45.38M $27.99M
YoY Change 62.1% 62.13% -39.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $507.1K $510.0K $306.3K
YoY Change 65.56% 64.52% -70.18%
Accrued Expenses $2.885M $2.880M $1.327M
YoY Change 117.35% 116.54% 416.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.392M $3.390M $1.634M
YoY Change 107.64% 107.98% 27.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.392M $3.390M $1.634M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.392M $3.390M $1.634M
YoY Change 107.64% 107.98% 27.24%
SHAREHOLDERS EQUITY
Retained Earnings -$86.45M -$68.24M
YoY Change 26.68% 42.56%
Common Stock $1.825K $1.280K
YoY Change 42.58% 1.03%
Preferred Stock
YoY Change
Treasury Stock (at cost) $40.71K $40.71K
YoY Change 0.0%
Treasury Stock Shares 5.710K shares 5.710K shares
Shareholders Equity $41.99M $41.99M $26.36M
YoY Change
Total Liabilities & Shareholders Equity $45.38M $45.38M $27.99M
YoY Change 62.1% 62.13% -39.29%

Cashflow Statement

Concept 2015 Q4 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$4.634M -$18.21M -$4.040M
YoY Change 14.7% -10.62% -7.97%
Depreciation, Depletion And Amortization $10.00K $30.00K $0.00
YoY Change 200.0%
Cash From Operating Activities -$2.920M -$15.36M -$3.690M
YoY Change -20.87% -11.24% -10.22%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $28.69K -$40.00K
YoY Change -100.0% -51.87%
Acquisitions
YoY Change
Other Investing Activities -$1.010M -$24.99M $0.00
YoY Change -125050.0%
Cash From Investing Activities -$1.010M -$25.02M -$40.00K
YoY Change 2425.0% 62446.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $32.44M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $32.72M -280.0K
YoY Change -100.0% -12683.2% -102.23%
NET CHANGE
Cash From Operating Activities -2.920M -$15.36M -3.690M
Cash From Investing Activities -1.010M -$25.02M -40.00K
Cash From Financing Activities 0.000 $32.72M -280.0K
Net Change In Cash -3.930M -$7.658M -4.010M
YoY Change -2.0% -56.49% -147.57%
FREE CASH FLOW
Cash From Operating Activities -$2.920M -$15.36M -$3.690M
Capital Expenditures $0.00 $28.69K -$40.00K
Free Cash Flow -$2.920M -$15.38M -$3.650M
YoY Change -20.0% -11.37% -11.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2014Q4 us-gaap Assets Current
AssetsCurrent
27895967 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2884794 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
306276 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
507067 USD
CY2014Q4 us-gaap Assets
Assets
27993502 USD
CY2015Q4 us-gaap Assets
Assets
45377278 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23753 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23753 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
128502659 USD
CY2014Q4 us-gaap Liabilities
Liabilities
1633532 USD
CY2015Q4 us-gaap Liabilities
Liabilities
3391861 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1633532 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3391861 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1327256 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
1825 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1280 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
26359970 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45377278 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27993502 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
41985417 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68237077 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86445455 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
40712 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
40712 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94636479 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
44877523 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
229912 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
350160 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27666055 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20007659 USD
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
24375168 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
0 USD
CY2015Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
144536 USD
CY2014Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 USD
CY2015Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
400252 USD
CY2014Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
0 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32900 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18241278 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15479446 USD
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001535955
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Accelerated Filer
CY2015Q2 dei Entity Public Float
EntityPublicFloat
145600000 USD
CY2015 dei Trading Symbol
TradingSymbol
LPCN
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18253456 shares
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75750 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Registrant Name
EntityRegistrantName
Lipocine Inc.
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1892835 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 USD
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.6
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
327000 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
295000 USD
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26721 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12580245 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5001368 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5801823 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
20480814 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
18382068 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-20480814 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-18382068 USD
CY2014 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
108338 USD
CY2015 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
173890 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20372476 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18208178 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 USD
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.11
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12766295 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16470814 shares
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.6
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.11
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12766295 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16470814 shares
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20372676 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-32900 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-20372676 USD
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14620 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1150418 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-540118 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
120248 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-449562 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
200791 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1070502 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1557538 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17304163 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15356304 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59608 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28689 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-38361 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-25018399 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16064 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
276994 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-255119 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
32716307 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17597643 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7658396 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45263698 USD
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
271183 USD
CY2015 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2015 us-gaap Payments For Deposits
PaymentsForDeposits
0 USD
CY2014 us-gaap Payments For Deposits
PaymentsForDeposits
-21247 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32439313 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
CY2014 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
40712 USD
CY2015 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
144536 USD
CY2014 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
0 USD
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
25789710 USD
CY2014 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
CY2014 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
0 USD
CY2015 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
-32900 USD
CY2015 us-gaap Accretion Expense
AccretionExpense
181390 USD
CY2014 us-gaap Accretion Expense
AccretionExpense
0 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
24407539 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
24375168 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
400781 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
400252 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
0 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
0 USD
CY2013Q3 lpcn Maximum Proceeds From Affiliates Under License Agreement
MaximumProceedsFromAffiliatesUnderLicenseAgreement
10000000 USD
CY2013Q3 lpcn Percentage Of Fee To Be Received
PercentageOfFeeToBeReceived
0.2 pure
CY2013Q3 lpcn Service Fee
ServiceFee
230 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
87000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
817395 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1060750 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1034029 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18250456 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800382 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18244746 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12794672 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
44823747 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1892835 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1150418 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56776 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
276994 USD
CY2014 lpcn Vesting Of Restricted Stock Awards Value
VestingOfRestrictedStockAwardsValue
0 USD
CY2015 lpcn Vesting Of Restricted Stock Awards Value
VestingOfRestrictedStockAwardsValue
0 USD
CY2014 lpcn Vesting Of Restricted Stock Units Value
VestingOfRestrictedStockUnitsValue
0 USD
CY2014 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
40712 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32439313 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
800000 USD
CY2014 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1041735 USD
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1014615 USD
CY2015Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
51404 USD
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
51404 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1136500 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1107811 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
200 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
200 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
200 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
200 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2014 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2015 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
200 USD
CY2014 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
200 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6190781 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6926642 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6691992 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7748579 USD
CY2015 lpcn Income Tax Rate Reconciliation Loss Of Tax Attributes Due To Change In Ownership
IncomeTaxRateReconciliationLossOfTaxAttributesDueToChangeInOwnership
0 USD
CY2014 lpcn Income Tax Rate Reconciliation Loss Of Tax Attributes Due To Change In Ownership
IncomeTaxRateReconciliationLossOfTaxAttributesDueToChangeInOwnership
-127572 USD
CY2015 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
4697 USD
CY2014 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
3792 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1713608 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1851668 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
23677332 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
17479654 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
59472 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
41568 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2052662 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1419165 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1150418 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1892835 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
215638 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
97656 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
28204501 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20889711 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
28200857 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20886811 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3644 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2900 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3644 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2900 USD
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3644 USD
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2900 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0175 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8139 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7630 pure
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18208378 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20372676 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18208378 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20372676 USD
CY2015Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
128000 USD
CY2014Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2400000 USD
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y22D
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
24808320 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
594 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
33494 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
24775420 USD
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
24808320 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
24775420 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
800000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7300000 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9200000 USD
CY2015 lpcn Operating Loss Carry Forwards Limitations On Use Amount
OperatingLossCarryForwardsLimitationsOnUseAmount
1100000 USD
CY2015 lpcn Operating Loss Carry Forwards Preownership Change Amount
OperatingLossCarryForwardsPreownershipChangeAmount
20200000 USD
CY2015 lpcn Operating Loss Forgive Pre Ownership Change Amount
OperatingLossForgivePreOwnershipChangeAmount
5500000 USD
CY2015 lpcn Tax Credit Carryforward Preownership Change Amount
TaxCreditCarryforwardPreownershipChangeAmount
1200000 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
59900000 USD
CY2015Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
1400000 USD
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
568000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
658000 USD
CY2015 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1 pure
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
74000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
48000 USD
CY2013Q3 lpcn Description Of Terms Of Service Agreement
DescriptionOfTermsOfServiceAgreement
Under the service agreement, the Company will provide facilities and up to 10 percent of the services of certain employees to Spriaso for a period of 18 months
CY2015Q4 lpcn Deferred Tax Assets Orphan Drug Tax Credit
DeferredTaxAssetsOrphanDrugTaxCredit
485789 USD
CY2014Q4 lpcn Deferred Tax Assets Orphan Drug Tax Credit
DeferredTaxAssetsOrphanDrugTaxCredit
0 USD
CY2015 lpcn Proceeds From Reimbursement
ProceedsFromReimbursement
61000 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5710 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5710 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
63.96
CY2015 lpcn Class Of Warrant Or Right Redemption Price Of Warrants Or Rights
ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
0.001
CY2015 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2018-11-12
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M13D
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.60
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -24.5pt; MARGIN: 0pt 0px 0pt 48.95pt; FONT: 10pt Times New Roman, Times, Serif"> </div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 24.45pt"></td> <td style="TEXT-ALIGN: left; WIDTH: 24.5pt"> <div><b><i>(a)</i></b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b><i>Use of Estimates</i></b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 48.95pt; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 48.95pt; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include those related to revenue recognition; stock-based compensation; valuation of deferred taxes; income tax uncertainties; and the useful lives of property and equipment.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
24903325 USD
CY2015Q4 lpcn Computer Equipment And Capitalized Computer Software Gross
ComputerEquipmentAndCapitalizedComputerSoftwareGross
43361 USD
CY2014Q4 lpcn Computer Equipment And Capitalized Computer Software Gross
ComputerEquipmentAndCapitalizedComputerSoftwareGross
41792 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
371373 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
387119 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
58903 USD
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
132 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
132 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
102221 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
45097 USD
CY2015 lpcn Income Tax Reconciliation Orphan Drug Tax Credits
IncomeTaxReconciliationOrphanDrugTaxCredits
155452 USD
CY2014 lpcn Income Tax Reconciliation Orphan Drug Tax Credits
IncomeTaxReconciliationOrphanDrugTaxCredits
0 USD
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
452609 USD
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
743186 USD

Files In Submission

Name View Source Status
0001144204-16-087232-index-headers.html Edgar Link pending
0001144204-16-087232-index.html Edgar Link pending
0001144204-16-087232.txt Edgar Link pending
0001144204-16-087232-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lpcn-20151231.xml Edgar Link completed
lpcn-20151231.xsd Edgar Link pending
lpcn-20151231_cal.xml Edgar Link unprocessable
lpcn-20151231_def.xml Edgar Link unprocessable
lpcn-20151231_lab.xml Edgar Link unprocessable
lpcn-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v432726_10k.htm Edgar Link pending
v432726_ex21-1.htm Edgar Link pending
v432726_ex23-1.htm Edgar Link pending
v432726_ex31-1.htm Edgar Link pending
v432726_ex31-2.htm Edgar Link pending
v432726_ex32-1.htm Edgar Link pending
v432726_ex32-2.htm Edgar Link pending